SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Everest Re Group, Ltd. (RE) trades at a trailing P/E of 9.6. Trailing earnings yield is 10.44%. PEG 0.77 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (72/100, Pass) — P/E is below market average (9.6); PEG ≤ 1.0 — Peter Lynch undervalued (0.77); earnings yield beats bond yields (10.44%).
- PEG Ratio 0.77 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 10.44% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $359.75 (+2.4% upside) — modest upside expected.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
72/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RE
Valuation Multiples
P/E (TTM)9.6
Forward P/EN/A
PEG Ratio0.77
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.87
EV/EBITDA0.0
Per Share Data
EPS (TTM)$36.66
Book Value / Share$0.00
Revenue / Share$403.13
FCF / Share$0.00
Yields & Fair Value
Earnings Yield10.44%
Dividend Yield0.00%
Analyst Target$359.75 (+2.4%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$23.68 |
$5.79B |
$996.34M |
17.2% |
| 2017 |
$11.36 |
$6.61B |
$468.97M |
7.1% |
| 2018 |
$2.53 |
$7.38B |
$103.55M |
1.4% |
| 2019 |
$24.70 |
$8.23B |
$1.01B |
12.3% |
| 2020 |
$12.78 |
$9.49B |
$514M |
5.4% |
| 2021 |
$34.62 |
$11.3B |
$1.38B |
12.2% |
| 2022 |
$15.10 |
$11.99B |
$597M |
5% |
| 2023 |
$60.24 |
$14.59B |
$2.52B |
17.3% |
| 2024 |
$32.58 |
$17.08B |
$1.37B |
8% |
| 2025 |
$36.66 |
$17.5B |
$1.59B |
9.1% |
